Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Therapeutics Inc (OTCQB:BTHE)

0.1251
Delayed Data
As of Feb 11
 0.00 / 0.00%
Today’s Change
0.03
Today|||52-Week Range
0.58
+14.35%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Squeglia Anthony Don
Chief Financial Officer
Buy3/10/201510,000$0.22$2.2K-48.81%
Esber Henry Jemil
Director
Buy3/18/20159,000$0.20$1.8K-37.45%
Hoberman Alan M
Director
Buy3/10/20155,000$0.22$1.1K-48.81%
Platt David
Chairman & Chief Executive Officer
Buy3/09/20153,000$0.21$630.00-48.94%
Platt David
Chairman & Chief Executive Officer
Buy3/09/20153,000$0.21$630.00-48.94%
Platt David
Chairman & Chief Executive Officer
Buy5/14/20155,000$0.12$600.00+4.25%
Conaway Dale H
Director
Buy5/15/20155,000$0.12$600.00+19.14%
Platt David
Chairman & Chief Executive Officer
Buy3/09/20152,285$0.23$525.55-48.94%
Platt David
Chairman & Chief Executive Officer
Buy3/09/20151,250$0.25$312.50-48.94%
Platt David
Chairman & Chief Executive Officer
Buy5/15/20151,000$0.15$150.00+19.14%
Page of 2